Intravitreal dexamethasone implant versus anti-vascular endothelial growth factor therapy combined with cataract surgery in patients with diabetic macular oedema: a systematic review with meta-analysis

MLA

Fallico, Matteo, et al. “Intravitreal Dexamethasone Implant versus Anti-Vascular Endothelial Growth Factor Therapy Combined with Cataract Surgery in Patients with Diabetic Macular Oedema: A Systematic Review with Meta-Analysis.” Eye, no. Preprints, Jan. 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1038/s41433-021-01847-w.

APA

Fallico, M., Lotery, A., Maugeri, A., Favara, G., Barchitta, M., Agodi, A., Russo, A., Longo, A., Bonfiglio, V., Avitabile, T., Marolo, P., Borrelli, E., Parisi, G., Cennamo, G., Furino, C., & Reibaldi, M. (2021). Intravitreal dexamethasone implant versus anti-vascular endothelial growth factor therapy combined with cataract surgery in patients with diabetic macular oedema: a systematic review with meta-analysis. Eye, Preprints, 1–8. https://doi.org/10.1038/s41433-021-01847-w

Chicago

Fallico, Matteo, Andrew Lotery, Andrea Maugeri, Giuliana Favara, Martina Barchitta, Antonella Agodi, Andrea Russo, et al. 2021. “Intravitreal Dexamethasone Implant versus Anti-Vascular Endothelial Growth Factor Therapy Combined with Cataract Surgery in Patients with Diabetic Macular Oedema: A Systematic Review with Meta-Analysis.” Eye, no. Preprints (January): 1–8. doi:10.1038/s41433-021-01847-w.